Santé & Pharma

Five Star Senior Living INC.

Flexion Therapeutics Inc

Fluidigm CORP

Foghorn Therapeutics Inc.

305 M

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forian Inc.

66 M

Forma Therapeutics Holdings, Inc.

Formycon AG

452 M

Forte Biosciences, Inc.

473 M

Forza Innovations Inc

252 k

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

11 Md

Fresenius SE & Co. KGaA

28 Md

Fulcrum Therapeutics, Inc.

446 M

Fulgent Genetics, Inc.

446 M

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

494 M

GBS Inc.

GBS Inc.

GENFIT

427 M

GENOWAY

30 M

GERON CORP

828 M

GLAUKOS Corp

6,5 Md

GMR Solutions Inc.

722 M

GRAIL, Inc.

3,5 Md

GROUPE TERA

7,9 M

GSK plc

75 Md

GT Biopharma, Inc.

20 M

GUERBET

126 M

GVS GVS

GVS SPA

806 M

GW Pharmaceuticals PLC

Gain Therapeutics, Inc.

75 M

Galderma Group AG

40 Md

Galectin Therapeutics INC

143 M

Galecto, Inc.

Galera Therapeutics, Inc.

16 M

Gamida Cell Ltd.

Gelesis Holdings, INC.

Gemini Therapeutics, Inc. /DE

Gemini Therapeutics, Inc. /DE

GeneDx Holdings Corp.

1,2 Md

Generation Bio Co.

Genesis Healthcare, Inc.

16 Md

Genovis AB

1,4 Md

Genufood Energy Enzymes Corp.

81 k

Gerresheimer AG

851 M